Clinical Trials · NCT01438034
Kisspeptin in the Evaluation of Delayed Puberty
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 24
- Start date
- Jun 2013
- Locations
- 1 site, United States
- Primary endpoint
- Average change in luteinizing hormone (LH) in response to kisspeptin